+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
UCB (Union chimique belge) - logo

UCB is a global biopharmaceutical company that focuses on neurology and immunology. The company’s core products are Cimzia, Vimpat, Neupro, Keppra and Briviact, and they are also preparing the launch of a potential medicine to help patients with osteoporosis. It offers products for the treatment of central nervous system disorders, allergy and respiratory diseases, and immune and inflammatory disorders. UCB employs over 7,000 people and is based in Brussels, Belgium.

From
Autoimmune Treatment Market Report 2025 - Product Thumbnail Image

Autoimmune Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Acute Repetitive Seizures Market - Global Forecast 2025-2032 - Product Thumbnail Image

Acute Repetitive Seizures Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 197 Pages
  • Global
From
Neurodegenerative Drugs Market - Global Forecast 2025-2032 - Product Thumbnail Image

Neurodegenerative Drugs Market - Global Forecast 2025-2032

  • Report
  • November 2025
  • 184 Pages
  • Global
From
Infantile Spasms Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Infantile Spasms Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 188 Pages
  • Global
From
From
From
Lacosamide Drugs Market - Global Forecast 2025-2030 - Product Thumbnail Image

Lacosamide Drugs Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 185 Pages
  • Global
From
Dravet Syndrome Market - Global Forecast 2025-2032 - Product Thumbnail Image

Dravet Syndrome Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 188 Pages
  • Global
From
From
From
Epilepsy Drug Market - Global Forecast 2025-2032 - Product Thumbnail Image

Epilepsy Drug Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 190 Pages
  • Global
From
Primary Immune Deficiency (PID) - Pipeline Insight, 2025 - Product Thumbnail Image

Primary Immune Deficiency (PID) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
From
Grand Mal Seizure Treatment Market Report 2025 - Product Thumbnail Image

Grand Mal Seizure Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Anticonvulsants Market Report 2025 - Product Thumbnail Image

Anticonvulsants Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Anti-Parkinson Drugs Market Report 2025 - Product Thumbnail Image

Anti-Parkinson Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
From
Loading Indicator